Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenPath Oncology is a leading clinical specialty laboratory division of BioReference Health, an OPKO Health company, specializing in cancer diagnostics. The company provides a comprehensive menu of oncology testing services, including next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), flow cytometry, and immunohistochemistry. GenPath focuses on delivering precise genomic information to oncologists and pathologists to guide personalized treatment decisions for both hematologic malignancies and solid tumors. Their proprietary OnkoSight platform offers advanced mutational profiling to identify actionable targets and prognostic markers in various cancer types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenPath Oncology.